Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093093 · ClinicalTrials.gov registry record · Phase 3
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 900
- Enrollment target
NCT00093093: Completed Phase 3 study, sponsored by Bausch Health Americas.
NCT00093093 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 900 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00093093, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 900 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of viramidine to ribavirin in chronic hepatitis C patients who have never before received treatment.
Interventions
- DRUG Ribavirin
- DRUG Viramidine
- DRUG pegylated interferon alfa-2a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-05 |
| Phase | Phase 3 |
What the finished NCT00093093 record still lists
NCT00093093 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 3 interventions - of which Ribavirin is the first listed.
NCT00093093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00093093 about?
NCT00093093 is a clinical study titled "Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive". The purpose of this study is to determine the safety and effectiveness of viramidine to ribavirin in chronic hepatitis C patients who have never before received treatment.
What is the current status of trial NCT00093093?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 900 participants. The study started on 2004-06. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00093093?
The interventions under investigation include: Ribavirin (DRUG), Viramidine (DRUG), pegylated interferon alfa-2a (DRUG).
Who is sponsoring clinical trial NCT00093093?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00093093's enrollment target sits among peer trials
900 350th of 2000 higher than 1,641 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia